SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-20-224764
Filing Date
2020-08-19
Accepted
2020-08-19 17:00:31
Documents
12
Period of Report
2020-08-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A d65473d8ka.htm   iXBRL 8-K/A 50991
  Complete submission text file 0001193125-20-224764.txt   177054

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wve-20200812.xsd EX-101.SCH 3091
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20200812_lab.xml EX-101.LAB 18019
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20200812_pre.xml EX-101.PRE 11384
5 EXTRACTED XBRL INSTANCE DOCUMENT d65473d8ka_htm.xml XML 4103
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37627 | Film No.: 201117650
SIC: 2834 Pharmaceutical Preparations